Longeveron (NASDAQ:LGVN) PT Raised to $12.00

Longeveron (NASDAQ:LGVN) had its price target boosted by research analysts at HC Wainwright from $6.00 to $12.00 in a report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock.

Longeveron Stock Up 1.2 %

LGVN opened at $1.71 on Monday. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.21. The firm has a market cap of $4.29 million, a P/E ratio of -0.17 and a beta of 0.22. Longeveron has a 52 week low of $1.60 and a 52 week high of $44.00. The business’s fifty day simple moving average is $3.62 and its 200 day simple moving average is $10.85.

Longeveron (NASDAQ:LGVN) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($2.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.10) by ($0.40). Longeveron had a negative return on equity of 209.14% and a negative net margin of 3,020.17%. The business had revenue of $0.06 million during the quarter, compared to analyst estimates of $0.21 million. As a group, equities research analysts anticipate that Longeveron will post -8.5 EPS for the current fiscal year.

Insider Buying and Selling at Longeveron

In other news, Director Rock Soffer bought 31,915 shares of the stock in a transaction on Thursday, April 11th. The shares were purchased at an average price of $2.35 per share, for a total transaction of $75,000.25. Following the completion of the purchase, the director now directly owns 208,534 shares of the company’s stock, valued at approximately $490,054.90. The purchase was disclosed in a filing with the SEC, which is available through this link. In related news, insider Joshua Hare purchased 106,383 shares of the firm’s stock in a transaction dated Wednesday, April 10th. The stock was bought at an average price of $2.35 per share, for a total transaction of $250,000.05. Following the purchase, the insider now owns 590,727 shares in the company, valued at approximately $1,388,208.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Rock Soffer bought 31,915 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $2.35 per share, with a total value of $75,000.25. Following the purchase, the director now owns 208,534 shares in the company, valued at $490,054.90. The disclosure for this purchase can be found here. Insiders have bought 148,936 shares of company stock worth $350,000 over the last 90 days. 24.34% of the stock is currently owned by corporate insiders.

Institutional Trading of Longeveron

An institutional investor recently bought a new position in Longeveron stock. Armistice Capital LLC bought a new position in Longeveron Inc. (NASDAQ:LGVN) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,836,000 shares of the company’s stock, valued at approximately $2,497,000. Armistice Capital LLC owned approximately 7.31% of Longeveron at the end of the most recent quarter. Institutional investors own 10.01% of the company’s stock.

About Longeveron

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.